Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Multimedia Files

Click on the video of interest to watch.

Click here to watch HBO "Addiction" Project Documentaries
Click here to see our podcast channel on iTunes.
Podcasts of the HBO documentary "Addiction" available for free download at iTunes
NAABT Public Service Announcements:
Replaced with Video
This page was last modified on : 12/01/2009
NABP Seal
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.